IP Library Granted Patent US 9,783,858
Granted Patent B2
US 9,783,858 · App. 14/677,239 · Granted Oct 10, 2017

Altered microbiome of chronic pelvic pain

Inventors: David J. Klumpp (Chicago, IL); Anthony J. Schaeffer (Hinsdale, IL); Bryan A. White (Champaign, IL)
Assignees: Northwestern University; Board of Trustees of the University of Illinois
C12Q1/689A61K35/74A61K35/741C12Q1/6883A61K2035/115
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,783,858
App. No.
14/677,239
Granted
Oct 10, 2017
Kind
B2
Abstract

Provided herein are kits, compositions, and methods for diagnosing and treating interstitial cystitis (IC) and/or interstitial cystitis/bladder pain syndrome (IC/BPS) based on finding lower levels of certain bacteria in a subject's stool sample (e.g., O. splanchnicus, F. prausnitzii, C. aerofaciens, E. sinensis, L. longoviformis , and R. intestinalis ). In certain embodiments, then present invention provides probiotic formulations containing live bacteria (e.g., from O. splanchnicus, F. prausnitzii, C. aerofaciens, E. sinensis, L. longoviformis , and R. intestinalis ).

Claims (8)

1. A method comprising:

testing, or having tested a stool sample from a subject suspected of suffering from interstitial cystitis (IC), to determine the level of bacteria from at least one bacterial species from a bacterial genus,

wherein said bacterial genus is selected from the group consisting of: Odoribacter, Faecalibacterium, Colinsella, Eggerthella, Lactonifactor , and Roseburia.

2. The method of claim 1 , wherein said at least one species is selected from the group consisting of: Odoribacter splanchnicus, Faecalibacterium prausnitzii, Colinsella aerofaciens, Eggerthella sinensis, Lactonifactor longoviformis , and Roseburia intestinalis.

3. The method of claim 1 , wherein said at least one species is at least two species selected from the group consisting of: Odoribacter splanchnicus, Faecalibacterium prausnitzii, Colinsella aerofaciens, Eggerthella sinensis, Lactonifactor longoviformis , and Roseburia intestinalis.

4. The method of claim 1 , wherein said at least one species is at least five species selected from the group consisting of: Odoribacter splanchnicus, Faecalibacterium prausnitzii, Colinsella aerofaciens, Eggerthella sinensis, Lactonifactor longoviformis , and Roseburia intestinalis.

5. The method of claim 1 , wherein said stool sample is tested with a sequencing assay specific to ribosomal RNA of said at least one species.

6. The method of claim 1 , further comprising comparing the level of bacteria to healthy control population levels.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jun 4, 2015
From: NORTHWESTERN UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035827/0783 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2015
From: KLUMPP, DAVID J.; SCHAEFFER, ANTHONY J.
To: NORTHWESTERN UNIVERSITY
Reel/Frame 035321/0624 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2015
From: WHITE, BRYAN A.
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 035321/0636 →
Continuity (2)
Provisional Application 61974277 · Apr 2, 2014
Related Publication 20150284781A1 · Oct 8, 2015